Trial ID: | L0779 |
Source ID: | NCT00399256
|
Associated Drug: |
Acetylcysteine
|
Title: |
Improved Estimation of GFR by Cystatin C in Preventing Contrast Induced Nephropathy by NAC or Zn
|
Acronym: |
|
Status: |
TERMINATED
|
Study Results: |
NO
|
Results: |
|
Conditions: |
Chronic Kidney Failure
|
Interventions: |
DRUG: Acetylcysteine|DRUG: Zinc
|
Outcome Measures: |
Primary: Incidence of acute renal failure | Secondary: Rise in creatinine of > 0.5 mg/dl|Rise in creatinine > 25%|Significant rise in serum cystatin C)
|
Sponsor/Collaborators: |
Sponsor: Robert Bosch Gesellschaft für Medizinische Forschung mbH
|
Gender: |
ALL
|
Age: |
ADULT, OLDER_ADULT
|
Phases: |
|
Enrollment: |
60
|
Study Type: |
INTERVENTIONAL
|
Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: PREVENTION
|
Start Date: |
2004-03
|
Completion Date: |
2006-03
|
Results First Posted: |
|
Last Update Posted: |
2007-02-01
|
Locations: |
Robert-Bosch-Hospital, Stuttgart, D-70376, Germany
|
URL: |
https://clinicaltrials.gov/show/NCT00399256
|